Blog

Zus

Creating the industry’s first shared development platform backed by a shared data record, Zus aims to bring about a better health data reality by empowering a wave of new, digital-first healthcare builders who will create digital health technologies and services that are cheaper, more customizable, and more personalized. This vision drives Zus to proactively connect the largest array of traditional medical providers to novel health data sources so that health data becomes frictionless to use.

1upHealth

1upHealth provides data interoperability between healthcare systems at a very low cost, fractions of a cent per API call, utilizing the latest FHIR® standards, and patient-authorized access, to ensure the best insights at the lowest costs across healthcare providers for low-income, diverse, and vulnerable populations.

Leyden Labs

Leyden Labs platform targets commonalities of viral families to protect humanity from known and future viruses.

AppliedVR

AppliedVR is a leader in digital therapeutics, pioneering virtual reality-based treatments that address the complexity of chronic pain with a mission to empower patients with the tools to live life, beyond chronic pain. Rooted in cognitive behavioral therapy and mindfulness, AppliedVR’s EaseVRx is the first VR-based prescription therapeutic to receive Breakthrough Device Designation by the FDA.

Ensoma

Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g. chemotherapy).

Equip

Equip delivers modern eating disorder treatment through family-based care that promises lasting recovery at home. Created by experts in the field and people who’ve been there, Equip provides each patient with a five-person dedicated care team including a therapist, dietician, physician, and peer & family mentor.

Atalanta Therapeutics

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.

ConnexPay

ConnexPay is revolutionizing the payment distribution process by offering a combined merchant acquiring and virtual card issuing solution for mid-sized companies. The company’s technology simplifies an antiquated workflow, eliminates the need for pre-funded accounts, reduces supplier risk and the cost of accepting card payments while safeguarding consumer spend. Backed by F-Prime Capital and BIP Capital, ConnexPay is becoming the industry leader in payments for industries historically viewed as high risk to payment providers.

Odaseva

Odaseva partners with the largest and most sophisticated organizations in the world to accelerate their trust in business-critical cloud applications. Fortune Global 500 industry leaders use Odaseva technology to back up and restore data, ensure data privacy and regulatory compliance, and use data to drive operational agility. Engineered for Salesforce by Salesforce experts and endorsed by Salesforce Ventures, Odaseva is trusted by 30+ million users and has received 100% five-star reviews over eight years on the Salesforce AppExchange.

Argyle

Argyle provides a single global access point to employment data. From that access point, any business can process verifications, gain real-time transparency into earnings as well as view and update worker profile details. By removing the barriers between a worker, the companies they make money from, and the business they buy services and products from Argyle has reimagined how employment data can be used. Argyle was founded in 2018 and operates out of New York.